Allworth Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Allworth Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Sell	1,270 -255	-17%	-$34.5K	﹤0.01%	1484
2026 Q1	$195K	Buy	1,525 +489	+47%	+$61K	﹤0.01%	1421
2025 Q4	$126K	Sell	1,036 -1,098	-51%	-$126K	﹤0.01%	1604
2025 Q3	$214K	Buy	2,134 +365	+21%	+$32.9K	﹤0.01%	1267
2025 Q2	$147K	Buy	1,769 +1,400	+379%	+$112K	﹤0.01%	1330
2025 Q1	$29.9K	Buy	369 +78	+27%	+$6.97K	﹤0.01%	1833
2024 Q4	$26.6K	Buy	291 +66	+29%	+$6.39K	﹤0.01%	1926
2024 Q3	$22.2K	Hold	225	–	–	﹤0.01%	1841
2024 Q2	$21.9K	Buy	225 +120	+114%	+$10.8K	﹤0.01%	1822
2024 Q1	$9.96K	Hold	105	–	–	﹤0.01%	2119
2023 Q4	$9.38K	Hold	105	–	–	﹤0.01%	2004
2023 Q3	$7.67K	Sell	105 -1	-0.9%	-$80	﹤0.01%	1944
2023 Q2	$8.82K	Hold	106	–	–	﹤0.01%	1900
2023 Q1	$8.08K	Buy	106 +57	+116%	+$4.73K	﹤0.01%	1867
2022 Q4	$4.07K	Hold	49	–	–	﹤0.01%	1979
2022 Q3	$4K	Sell	49 -99	-67%	-$8.35K	﹤0.01%	1983
2022 Q2	$11K	Hold	148	–	–	﹤0.01%	1556
2022 Q1	$13K	Hold	148	–	–	﹤0.01%	1421
2021 Q4	$17K	Buy	148 +100	+208%	+$12.1K	﹤0.01%	1191
2021 Q3	$6K	Hold	48	–	–	﹤0.01%	1500
2021 Q2	$6K	Hold	48	–	–	﹤0.01%	1185
2021 Q1	$7K	Hold	48	–	–	﹤0.01%	1075
2020 Q4	$7K	Hold	48	–	–	﹤0.01%	929
2020 Q3	$5K	Hold	48	–	–	﹤0.01%	861
2020 Q2	$5K	Hold	48	–	–	﹤0.01%	880
2020 Q1	$4K	Sell	48 -103	-68%	-$9.12K	﹤0.01%	946
2019 Q4	$14K	Buy	151 +103	+215%	+$8.91K	﹤0.01%	591
2019 Q3	$4K	Sell	48 -122	-72%	-$10.1K	﹤0.01%	733
2019 Q2	$15K	Hold	170	–	–	﹤0.01%	515
2019 Q1	$15K	Hold	170	–	–	﹤0.01%	514
2018 Q4	$12K	Hold	170	–	–	﹤0.01%	494
2018 Q3	$16K	Hold	170	–	–	﹤0.01%	476
2018 Q2	$16K	Hold	170	–	–	﹤0.01%	448
2018 Q1	$15K	Hold	170	–	–	﹤0.01%	421
2017 Q4	$14K	Hold	170	–	–	﹤0.01%	431
2017 Q3	$15K	Buy	170 +122	+254%	+$9.78K	﹤0.01%	414
2017 Q2	$4K	Sell	48 -142	-75%	-$10.1K	﹤0.01%	609
2017 Q1	$13K	Buy	+190	New	+$12.8K	﹤0.01%	420
2016 Q2	–	Sell	-702	Closed	-$36K	–	687
2016 Q1	$36K	Buy	702 +300	+75%	+$15.6K	﹤0.01%	243
2015 Q4	$28K	Hold	402	–	–	0.01%	264
2015 Q3	$25K	Buy	+402	New	+$31.7K	0.01%	286

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Allworth Financial's XBI Position: Q2 2026 in Review

Allworth Financial reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 17% in Q2 2026, selling an estimated $34.5K and leaving 1,270 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

Allworth Financial first reported a position in XBI in Q3 2015 and has held it in 41 quarters since. The position peaked at $214K in Q3 2025. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Allworth Financial held 1,270 shares of State Street SPDR S&P Biotech ETF worth $201K as of Q2 2026.
Allworth Financial sold 255 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $34.5K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1484 holding.
Allworth Financial first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and has held it in 41 quarters since.
Allworth Financial's State Street SPDR S&P Biotech ETF position peaked at $214K in Q3 2025.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.